Auximines Clinical Solutions(SRL)

BE 0669.694.136

Voetbalstraat 17,1981Zemst

Financial data from Auximines Clinical Solutions

	2023		2022		2021		2020
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ 62.250	-71%	€ 218.018	86%	€ 116.966	19%	€ 98.509
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 250.314	32%	€ 189.663	-55%	€ 421.645	38%	€ 306.278
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 36.672	-39%	€ 60.112	-70%	€ 198.996	33%	€ 149.529

Publications in the Belgian Official Journal from Auximines Clinical Solutions

	Date	Publication
	07-07-2022	Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations - Appointments (NL)
	30-06-2017	Miscellaneous (FR)
	02-06-2017	Miscellaneous (FR)
	19-01-2017	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Auximines Clinical Solutions?

The VAT number of Auximines Clinical Solutions is BE0669694136.

When was Auximines Clinical Solutions founded?

Auximines Clinical Solutions was founded on 17-01-2017.

What is the address of Auximines Clinical Solutions?

The current registered office of Auximines Clinical Solutions is located at Voetbalstraat 17, 1981 Zemst.

When was the last time Auximines Clinical Solutions filed their annual financial statements?

The most recent financial statements of Auximines Clinical Solutions were filed on 17-06-2024. You can view them here.

How many employees does Auximines Clinical Solutions have?

There are currently no employees working at Auximines Clinical Solutions or no workforce information is available.

What is the annual turnover of Auximines Clinical Solutions?

At the time of its most recent financial statements, Auximines Clinical Solutions did not publish any turnover figures. Auximines Clinical Solutions reported a gross margin of €36,672.80.